Maintenance of murine long-term repopulating stem cells in ex vivo culture is affected by modulation of transforming growth factor-β but not macrophage inflammatory protein-1α activities

Blood

Volumn 87, Issue 11, 1996, Pages 4561-4567

  Soma, Toshihiro ^a   Yu, Jian Mei ^a   Dunbar, Cynthia E ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 3; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; GENE THERAPY; GROWTH REGULATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 9044237272     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.11.4561.bloodjournal87114561     Document Type: Article

References (42)

1. Roberts A, Sporn M: Physiological actions and applications of transforming growth factor β. Growth Factors 8:1, 1993
2. Nilsen-Hamilton M: Transforming growth factor-β and its actions on cellular growth and differentiation. Curr Topics Develop Bio 24:95, 1990
3. Jacobsen SEW, Keller JR, Ruscetti FW, Kondaiah P, Roberts AB, Falk LA: Bidirectional effects of transforming growth factor β (TGF-β) on colony-stimulating factor-induced human myelopoiesis in vitro: Differential effects of distinct TGF-β isoforms. Blood 78:2239, 1991
4. Hooper WC: The role transforming growth factor-β in hematopoiesis: A review. Leuk Res 15:179, 1991
5. Wahl SM: TGF-β in inflammation: A cause and a cure. J Clin Immunol 12:61, 1992
6. Ruscetti FW, Dubois CM, Jacobsen SE, Keller JR: Transforming growth factor β and interleukin-1 : A paradigm for opposing regulation of haemopoiesis. Baillieres Clin Haematol 5:703, 1992
7. Lahm H, Odartchenko N: Role of transforming growth factor β in colorectal carcinoma. Growth Factors 9:1, 1993
8. Christ M, McCartney-Francis NL, Kulkarni AB, Ward JM, Mizel DE, Mackall CL, Gress RE, Hines KL, Tian H, Karlsson S, Wahl SM: Immune dysregulation in TGF-β1-deficient mice. J Immunol 153:1936, 1994
9. Han ZC, Caen JP: Cytokines acting on committed haematopoietic progenitors. Baillieres Clin Haematol 7:65, 1994
10. Hestdal K, Jacobsen SEW, Ruscetti FW, Longo DL, Boone TC, Keller JR: Increased granulopoiesis after sequential administration of transforming growth factor-β1 and granulocyte-macrophage colony-stimulating factor. Exp Hematol 21:799, 1993
11. Hayashi S, Gimble JM, Henley A, Ellingsworth LR, Kincade PW: Differential effects of TGF-β1 on lymphohemopoiesis in long-term bone marrow cultures. Blood 74:1711, 1989
12. Eaves CJ, Cashman JD, Ray RJ, Dougherty GJ, Otsuka J, Gaboury LA, Hogge DE, Lansdorp DM, Eaves AC, Humphries RK: Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 78:110, 1991
13. Waegell WO, Higley HR, Kincade PW, Dasch JR: Growth acceleration and stem cell expansion in Dexter-type cultures by neutralization of TGF-β. Exp Hematol 22:1051, 1994
14. Carlino JA, Higley HR, Creson JR, Avis PD, Ogawa Y, Ellingsworth LR: Transforming growth factor β1 systemically modulates granuloid, erythroid, lymphoid, and thrombocytic cells in mice. Exp Hematol 20:943, 1992
15. Hatzfeld J, Li M, Brown EL, Sookdeo H, Levesque J, O'Toole T, Gurney C, Clark SC, Hatzfeld A: Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor β1 oligonucleotides. J Exp Med 174:925, 1991
16. Graham GJ, Wright EG, Hewick R, Wolpe SD, Wilkie NM, Donaldson D, Lorimore S, Pragnell IB: Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature 344:442, 1990
17. Broxmeyer HE, Sherry B, Cooper S, LU L, Maze R, Beckmann MP, Cerami A, Ralph P: Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. J Immunol 150:3448, 1993
18. Keller JR, Bartelmez SH, Sitnicka E, Ruscetti FW, Ortiz M, Gooya JM, Jacobsen SEW: Distinct and overlapping direct effects of macrophage inflammatory protein-1α and transforming growth factor β on hematopoietic progenitor/stem cell growth. Blood 84:2175, 1994
19. Dunlop DJ, Wright EG, Lorimore S, Graham GJ, Holyoake T, Kerr DJ, Wolpe SD, Pragnell IB: Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP1α in vivo. Blood 79:2221, 1992
20. Lord BI, Dexter TM, Clements JM, Hunter MA, Gearing AJH: Macrophage-inflammatory protein protects multipotent hematopoietic cells from the cytotoxic effects of hydroxyurea in vivo. Blood 79:2605, 1992
21. Verfaillie CM, Cateanzarro PM, Li WN: Macrophage inflammatory protein 1α, interleukin 3 and diffusable marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro. J Exp Med 179:643, 1994
22. Verfaillie CM, Miller JS: CD34+/CD33- cells present in MIP-1α+IL3 supplemented "stroma-non-contact" cultures contain more than 20 percent primitive progenitors that can reinitiate long-term cultures. Blood 84:1442, 1994
23. Harrison DE, Jordan CT, Zhong RK, Astle CM: Primitive hemopoietic stem cells: Direct assay of most productive repopulation with simple binomial, correlation and covariance calculations. Exp Hematol 21:206, 1993
24. Bodine DM, Crosier PS, Clark SC: Effects of hematopoietic growth factors on the survival of primitive stem cells in liquid suspension culture. Blood 78:914, 1991
25. Dasch JR, Pace DR, Waegell W, Inenaga D, Ellingsworth L: Monoclonal antibodies recognizing transforming growth factor-β. Bioactivity neutralization and transforming growth factor β-2 affinity purification. J Immunol 142:1536, 1989
26. Till JE, McCulloch EA: A direct measurement of radiation sensitivity of normal mouse bone marrow cells: Evidence for a pre-CFU-S cell. Nature 281:381, 1979
27. Dunbar CE, Crosier PS, Nienhuis AW: Introduction of an activated RAS oncogene into murine bone marrow lymphoid progenitors via retroviral gene transfer results in thymic lymphomas. Oncol Res 6:39, 1991
28. Bodine DM, McDonagh KT, Seidel NE, Nienhuis AW: Survival and retrovirus infection of murine hematopoietic stem cells in vitro: Effects of 5-FU and method of infection. Exp Hematol 19:206, 1991
29. Barker JE, Greer J, Bacon S, Compton ST: Temporal replacement of donor erythrocytes and leukocytes in nonanemic W44j/W44j and severely anemic W/Wv mice. Blood 78:1432, 1991
30. Jacobsen SE, Ruscetti FW, Dubois CM, Lee J, Boone TC, Keller JR: Transforming growth factor-β trans-modulates the expression of colony stimulating factor receptors on murine hematopoietic progenitor cell lines. Blood 77:1706, 1991
31. Dubois CM, Ruscetti FW, Stankova J, Keller JR: Transforming growth factor-β regulates c-kit message stability and cell-surface protein expression in hematopoietic progenitors. Blood 83:3138, 1994
32. Jacobsen FW, Stokke T, Jacobsen SEW: Transforming growth factor-β potently inhibits the viability-promoting activity of stem cell factor and other cytokines and induces apoptosis of primitive murine hematopoietic progenitor cells. Blood 86:2957, 1995
33. Quesniaux VFJ, Graham GJ, Pragnell I, Donaldson D, Wolpe SD, Iscove N, Fagg B: Use of 5-fluorouracil to analyze the effect of macrophage inflammatory protein-1α on long-term reconstituting stem cells in vivo. Blood 81:1497, 1993
34. Uchida N, Fleming WH, Alpern EJ, Weissman IL: Heterogeneity of hematopoietic stem cells. Curr Opin Immunol 5:177, 1993
35. Moritz T, Patel VP, Williams DA: Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J Clin Invest 93:1451, 1994
36. Dunbar CE, Cottler-Fox M, O'Shaughnessy JA, Doren S, Carter CS, Berenson R, Brown S, Moen RC, Greenblatt J, Stewart FM, Leitman SF, Wilson W, Cowan KH, Young NS, Nienhuis AW: Retrovirally-marked CD34-enriched peripheral blood and bone marrow and cells contribute to long-term engraftment after autologous transplantation. Blood 85:3048, 1995
37. Dunbar CE, Emmons RVB: Gene transfer into hematopoietic progenitor and stem cells: Progress and problems. Stem Cells 12:563, 1994
38. Miller DG, Adam MA, Miller AP: Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10:4239, 1990
39. Harrison DE, Lerner CP: Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluoro-uracil. Blood 78:1237, 1991
40. Knobel KM, McNally MA, Berson AE, Rood D, Chen K, Kilinski L, Tran K, Okarma TB, Lebkowski JS; Long-term reconstitution of mice after ex vivo expansion of bone marrow cells: Differential activity of cultured bone marrow and enriched stem cell populations. Exp Hematol 22:1227, 1994
41. Williams DA: Ex-vivo expansion of hematopoietic stem and progenitor cells - Robbing Peter to pay Paul? Blood 81:3169, 1993
42. Peters SO, Kittler ELW, Ramshaw HS, Quesenberry PJ: Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts. Exp Hematol 23:461, 1995